Greenberg Traurig Representing Patient Square Capital in Acquisition of Paradigm

NEW YORK - Feb. 13, 2026 - Global law firm Greenberg Traurig, LLP is representing Patient Square Capital in connection with its acquisition of Paradigm, a specialty care management organization focused on delivering solutions that improve outcomes for individuals with complex injuries and diagnoses.

Paradigm has been a pioneer in value-based care for nearly 35 years, impacting complex, high-cost care and spend categories through risk-based clinical solutions and case management, specialty networks, home health, shared decision support, and payment integrity programs.

Patient Square Capital is a dedicated health care investment firm with approximately $17 billion in assets under management. Patient Square Capital aims to achieve strong investment returns by partnering with growth-oriented companies and top-tier management teams whose products, services, and technologies improve health.

The Greenberg Traurig team that is representing Patient Square Capital is led by Ejim Peter Achi, co-chair of the firm's Global Corporate Practice and its Private Equity Practice, and New York Corporate Shareholder Sung Jin. Other shareholders include Richard C. Kim (Corporate, New York), Alexander M. Mandel (Corporate, New York), Alexander Sellinger (Corporate, New York), P. Fishel Schreiber (Benefits & Compensation, New York), Jeffrey K. Ekeberg (Tax, Chicago), Tricia A. Asaro ( Health Care & FDA Practice, Albany), Nicholas J. Diamond (Health Care & FDA Practice, Houston), Julie A. Sullivan (Health Care & FDA Practice, Denver), Tamara Rizkalla (Health Care & FDA Practice, Washington, D.C.), Eileen M. Hayes (Health Care & FDA Practice, Albany), Evangelia Podaras (Labor & Employment, New York), David M. Greenberg (Intellectual Property & Technology, New York), Sean W. Bezark (Environmental, Chicago), and Stephen M. Pepper (Antitrust Litigation & Competition Regulation, New York).

The team also included of counsel: Elizabeth Corliss Sacco (Health Care & FDA Practice, Albany), Tzy-Ying (Sandy) Chiu (Intellectual Property & Technology, New York), Lucas Kilravey (Real Estate, New York), and Rebecca Tracy Rotem (Antitrust Litigation & Competition Regulation, Washington, D.C.), and Associates: Abdulrasheed Bolaji Ijaodola (Corporate, New York), Sophie A. Korn (Corporate, Atlanta), Seung Won "Selina" Yoo (Corporate, New York), Holland (Holly) Goldsmith (Benefits & Compensation, New York), Alexandra Studwell (Benefits & Compensation, New York), Nicole Baptiste (Health Care & FDA Practice, Washington, D.C.), Ashley Wollaston (Health Care & FDA Practice, Houston), Sukhdeep S. Gill (Intellectual Property & Technology, Philadelphia), Korede Sotubo (Corporate/Real Estate, New York), and law clerk/JDs: Vincent Okonkwo (Corporate, New York) and Maura McKendrick (Corporate, New York).